November 30 (SeeNews) - Bulgarian drug distributor Sopharma Trading [BUL:SO5] said its consolidated net profit fell to 7.5 million levs ($4.55 million/3.83 million euro) in the first nine months of 2017, from 8.5 million levs in the prior-year period.
The company’s revenue rose to 504.1 million levs in the period under review, from 447.9 million levs the year before, Sopharma Trading said in a bourse filing on Wednesday.
Cost of goods sold increased to 464.6 million levs in January-September, from 413.5 million levs in the corresponding period of last year.
Sopharma Trading is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:3JR].
(1 euro = 1.95583 levs)